TAMPA, Fla., March 15, 2018 (GLOBE NEWSWIRE) -- United Consortium Ltd. (OTC PINK:UCSO), an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Blockchain, Digital Media and the Emerging Cannabis Space, today announced that its wholly owned subsidiary Block Chain, Inc. has launched the beta version of its new PHR Blockchain project.
UCL Chairman and Chief Executive Officer Scott Gallagher stated, “Today marks an important step forward in our journey to turn our blockchain based idea, into a viable business opportunity with the potential to disrupt how we access and utilize our health records.” Gallagher continued, “We expect the beta period to last several months as we test our methods, collect data and tackle some of the hurdles we’ve identified. Our plan is to have the public version 1.0 set for release this summer. Version 1.0 will have a valuable set of user tools that will transfer complete ownership of personal health records back where it belongs, to the patient.”
About United Consortium Ltd. (UCL)
UCL is an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Blockchain, Digital Media and the Emerging Cannabis Space. The Company is headquartered in Tampa, Florida. UCL is a current pink sheet Company. The most current information about the Company can be found on OTCMarkets.com or by visiting the Company's website at www.UCLVentures.com.
This release contains forward-looking statements that relate to future events or United Consortium Ltd. (UCL's) future performance or financial condition. Any statements that are not statements of historical fact, such as the statements above and including statements containing the words "plans," "anticipates," "expects" and similar expressions, should also be considered to be forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as result of a number of factors, including those described from time to time in United Consortium Ltd.’s filings with the Securities and Exchange Commission, OTC Markets or statement on the Companies websites. United Consortium Ltd. And all of its subsidiary companies undertakes no duty to update any forward-looking statements made herein.
For additional information contact:
Source:United Consortium, Ltd.